Kirit M. Ardeshna

5.8k citations
120 papers · 3.3k indexed · 2 hit papers · h-index 27
Topics
Lymphoma Diagnosis and Treatment (84 papers)Chronic Lymphocytic Leukemia Research (31 papers)CAR-T cell therapy research (29 papers)
Journals
The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Kirit M. Ardeshna

118 papers receiving 3.2k citations

Hit Papers

Rituximab plus cyclophosphamide, doxorubicin, vincristine...201320262017202120132021100200300

Peers

Kirit M. Ardeshna
Comparison fields: 5 of 98
  • Pathology and Forensic Medicine 2.1k
  • Oncology 1.9k
  • Genetics 758
  • Immunology 688
  • Neurology 665
Replace Hans–Konrad Müller–Hermelink with:
Hans–Konrad Müller–Hermelink Germany
Alexandra Traverse‐Glehen France
Jean Gabarre France
Jakub Svoboda United States
Hans‐Dieter Foss Germany
Yoshitoyo Kagami Japan
Andreas H. Sarris United States
Sunita D. Nasta United States
Lode J. Swinnen United States
Diying Shen China
Kirit M. Ardeshna relative to Hans–Konrad Müller–Hermelink Germany Hans–Konrad Müller–Hermelink's profile →
Citations per field
00.5×4.3×
Hans–Konrad Müller–Hermelink · 1×
Citations per year

Countries citing papers authored by Kirit M. Ardeshna

Since Specialization
Citations

This map shows the geographic impact of Kirit M. Ardeshna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirit M. Ardeshna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirit M. Ardeshna more than expected).

Fields of papers citing papers by Kirit M. Ardeshna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirit M. Ardeshna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirit M. Ardeshna. The network helps show where Kirit M. Ardeshna may publish in the future.

Co-authorship network of co-authors of Kirit M. Ardeshna

This figure shows the co-authorship network connecting the top 25 collaborators of Kirit M. Ardeshna. A scholar is included among the top collaborators of Kirit M. Ardeshna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirit M. Ardeshna. Kirit M. Ardeshna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 5
3 1
4 7
5 122
6 47
7 6
8 49
9 52
10 77
11 6
12 6
13 3
14 31
15 22
16 9
17 4
18 5
19
The long-term impact of a watch and wait policy vs immediate systemic treatment for asymptomatic advanced stage indolent non Hodgkins lymphoma: Results of a British national lymphoma randomised trial
0
20 5

About Kirit M. Ardeshna

Kirit M. Ardeshna is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 120 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (84 papers), Chronic Lymphocytic Leukemia Research (31 papers) and CAR-T cell therapy research (29 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.1k citations), Genetics (758 citations) and Oncology (1.9k citations). Kirit M. Ardeshna has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Stephen Devereux, Asim Khwaja, Arnold Pizzey, David C. Linch, John Radford, Andrew McMillan, David Cunningham, Christopher Pocock, Wendi Qian and Andrew Jack. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026